SPECTACULAR CLINICAL RESULTS OBTAINED THROUGH METATHERAPY
Treating the patient without adverse effect is possible by correcting the electric patterns of the biological object.
Dr. M.Gheorghiu, Dr. T.Trandafir
How Metatherapy work:
The cells from a tissue have the capacity of emitting bio-fields, with the same physical characteristics.
They resonate with great ease, thus a tissue or a functional organ is characterized through the synchronicity of its cells.
They can enter into resonance with any other interior or exterior
field, if their physical dimensions are compatible. These fields are malleable, hence their preservation and edification participates mostly to the dipole water molecules.
The limits of variability are thus not great.
Water molecules constitutes the essential elements in the edification and malleability of the cellular bio-field. These molecules are structural, yet their alteration in any way leads to the death of the cellular system, as a group “with a single element” from the crowd theory.
Through the influence of the bio-fields, water molecules can form spatial structures, which are engrams of the principle bio-field. Water can form as many engrams as fields that exist in the universe.
Isolated and photographed water crystals by Japanese researchers leave no doubt in this sense.
A similar structure acts as a liquid crystal containing the
information and the vehicle of information. The information contained in a water crystal can be “read” by any structure that possesses the capacity of recreating the initial generator field.
The decoding is a resonance process, while the resonator can be placed at a distance of the codifier.
The capacity of generating fields is general, but certain cells, such as neurons, possess a “high specialization”.
Some of these fields function at low frequencies, between 4 and 12 Hz.
The fields with frequencies over 150,000 Hz are just intuited and not characterized as having a physiological significance. The capacity of generating these fields is characteristic of all cells derived from the neural tube, including the endocrine cells. Homeostasis is genetically inscribed as a hologram in all the decisional areas of the central nervous system (CNS), somatic or vegetative.
From this point of view, any diseased state is a different hologram, outside the admissible limits of the normal hologram.An abnormal hologram tends to be corrected by the neuro-endocrine coordination. The incapacity of correcting, regardless of the cause (central or peripheral), leads to the appearance of clinical disease.
The afferent and efferent signs have intermediary states on their trajectory, which function as resonators. The primary signal interferes with the signals received from the resonators, the result being a modulation in frequency, of a wave impulse type.
The Metatron device intercepts certain characteristics of the biofield, such as the electro-magnetic type.
Thus, received information is compared with the stored data in the memory and suggests the similitude of modified fields in certain disease states.
In fact, the equipment performs a spectral analysis of the magnetic field of any biological structure.
The fundamental principle in the development of the equipment is as follows: the human organism has an informational electromagnetic imprint that is capable of interfering with external electromagnetic stimuli.
A tissue that emits a cellular frequency that is characteristic of the individual who is tested.
Finally, the system stabilizes the grade of similarity with a standard cell/tissue, healthy or pathologically modified.
The Metatron device also has the capacity of generating corrector fields that act as similar pattern as the ancestral ones, including the individual’s genetic code.
These corrector fields can have an action upon the following:
On the superior nervous centers and endocrine glands
On the resonators
On the cells, tissues and organs
Thus, the applied “electromagnetic treatment” can correct the electromagnetic behavior of the treated tissue, thus it can bring back the biochemical reactions to a level that corresponds to a normal tissue.
Randoms spectacular results obtained by metatherapy:
• Reduction in thedimensions until disappearance of benign tumors (ovarian cysts, uterine fibromes, fibrocystic mastopathy, synovial cysts).
• Maintenance of a disuresis of 500-1000ml/24 hours (isostenuria), of a hemodyalized patient for a year and a half.
• 3 year treatment of a patient with chronic myeloid
leukemia (associated with chemotherapy with Glivec).
• Partial restructuring of cardiac valves (reduction of a mitral insufficiency)
• Rapid biliary drainage; treatment of reno-vesicula lithiasis.
• Stabilization of certain forms of viral hepatitis (B and C), without conventional therapy.
The work presents 3 clinical cases with unique results through metatheraphy:
Multiple sclerosis, deep and superficial venous thrombosis of the lower limb on a patient with congenital hypercoagulation, fungoides mycosis in the state of cutaneous lymphoma of the T cell type.
The first two cases have presented with spectacular remissions after several sessions of metatherapy, remissions that have been stable for at least a year.
In the later case, the cutaneous lesions have disappeared after the first treatment, but reappear if the patient dismisses the treatment more than a month.
Metatheraphy has been introduced to the patient 3 and a half years ago, and during this time the patient refused treatment with interferon, without the disease progressing
Female patient, 24 years of age with M.S. (multiple sclerosis).
Hospitalized March 2009 at the Elias Hospital in Bucharest with the diagnosis of diplopy recently installed.
MRI cranio-encephalic with contrast medium on 06.03.2009:
-3 active demyelinized lesions: one of 9/3 mm right subcortical right, another 9/6mm tangential with the left subventricular wall and another 7/3 mm right
-2 demyelinized lesions: one of 10/4 mm prerependicular on the right lateral ventricle and another 8/6mm perpendicular on the left lateral ventricle (posterior horn).
- Conclusion: the demyelinized bilateral supratentorial lesions, some with a certain active characteristic, with an aspect suggestive of M.S.; necessitates correlation with the clinic-biological data.
MRI cranio-encephalic with contrast medium on 26.01.2010 (after 6 metatherapy sessions and
without any other applied therapy)
-2 demyelinized lesions 7.5 and 5.5mm localized on the right parietal, supraventricular lobe.
-1 demyelinized lesion with lowered activation grade approximately 3.3 mm localized on the left parietal, supraventricular
3.06.09, 9.06.09, 18.06.09, 26.06.09, 17.07.09,
Female patient 32 years of age with D.I. Congenital deficiency of protein C anticoagulation.
Diagnosis: Left Ilio-femoro-popliteal thrombosis post surgical intervention for the excision of the right great saphenous vein.
ECHO DOPPLER – venous inferior limb 04.02.2009 Left inferior limb
• Ilio-femoro-popliteal thrombosis. Superior pole of the thrombus reaches the left common iliac vein , whose residual diameter at compression is 10mm.
• The residual diameter at compression of the external iliac vein is 12mm
• The common femoral vein: 15mm, with a small canal that circulates peripherally
• Superficial femoral vein: 8mm, without signs of repermeabilization
• A peroneal vein compressible, the other with a residual diameter of 4.4mm
• Thrombosis of one of the solear veins.
• Great saphenous vein: normal
• Lesser saphenous vein with the superior pole at the sapheno-popliteal junction, diameter at compression of
ECO DOPPLER – venous inferior limb 27.05.2009
Left inferior limb
• Ilio-femoro-popliteal thrombosis in process of canalization.
• Residual diameter at compression:
• Common iliac vein 3.5mm
• External iliac vein 4mm
• Common femoral vein 3.5mm
• External iliac vein 4mm
• Common femoral vein 3.5mm
• Superficial femoral vein 6mm
• Popliteal vein 2.3mm
• Peronial veins are compressible
• 2. Great saphenous vein: normal
• Lesser saphenous vein partically compressible with a residual lumen circa 2mm
Four (4) sessions of metatherapy were actualized, in the conditions in which anticoagulation therapy was deemed efficient for at least 6 months.
Female patient 68 years of age with T.D. Diagnosis: fungoides mycosis in the presence of a cutaneous T cell lymphoma.
The patient presents on 11.01.2007 for evaluation through telemetric non-linear analysis (Metatron method), being already diagnosed with fungoides mycosis in the presence of a T cell cutaneous lymphoma.
At the moment of examination, the presence of extensive thoracic lesions, as well as on the abdomen and limbs, especially at the level of elbow and inguinal plicae.
The first session of metatherapy was performed and lead to a spectacular recession of the cutaneous lesions, the patient no longer using topical ointments. This
remission of the lesions maintained itself as long as the patient repeated
the treatment at an interval 1-3 weeks.
The prolongation of the intervals determined a reappearance of the lesions.
The patient decided herself to quit the interferon therapy in 2007 due to the adverse reactions that she could no longer tolerate.
In the period from 2007 and May 2010, the patient did not present with significant modification of the hemoleukograme and other hematologic tests that were performed. Also, secondary changes of the internal organs did not manifest.
Besides the cardio-vascular medicine and local emollients, no other treatment was used besides metatherapy.
At the moment, the patient is in Switzerland for specialized investigations.
Astonishingly is the extreme tissue receptivity at the treatment with electromagnetic waves, the lesions regressing 12-48 hours from the time of therapy.